돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 235생성일: 2026년 10월 24일

1-Benzylpiperazine → Ethyl 4-(4-benzylpiperazin-1-yl)benzofuran-2-carboxylate

https://huagongshe.com/ko/reaction/235

반응식

참여 물질

역할이름HCID투입량
반응물1-BenzylpiperazineHCID 75994—
반응물Ethyl 4-bromobenzofuran-2-carboxylateHCID 21838105—
시약Cesium carbonateHCID 10796—
촉매Bis(dibenzylideneacetone)palladiumHCID 9811564—
촉매2-Dicyclohexylphosphino-2',4',6'-triisoprophylbiphenylHCID 11155794—
용매1,4-DioxaneHCID 31275—
생성물Ethyl 4-(4-benzylpiperazin-1-yl)benzofuran-2-carboxylateHCID 6798269131.9%

반응 조건

온도95 °C

반응 단계

ethyl 4-bromobenzofuran-2-carboxylate (5 g, 18.58 mmol), 1-benzylpiperazine (3.22 mL, 18.58 mmol), 2-Dicyclohexylphosphino-2',4',6'-tri-iso- propyl-1,1'-biphenyl (0.886 g, 1.86 mmol), Tris(dibenzylideneacetone)dipalladium(0) (0.851 g, 0.93 mmol) and CESIUM CARBONATE (7.87 g, 24.16 mmol) were heated under argon to 95 °C overnight. The mixture was allowed to cool. The mixture was diluted with EtOAc and the mixture was filtered through a pad of Celite. The filterate was collected and the solvent was removed by rotary evaporation. The crude product was added to a silica gel column and was eluted with 0-50% EtOAc in heptane. The collected fractions were combined and the solvent was removed to yield ethyl 4-(4-benzylpiperazin-1-yl)benzofuran-2-carboxylate (2.160 g, 31.9 %). MS (m+1) = 365.6. HPLC Peak RT = 3.30 minutes is product. Purity = 94%.

출처 및 근거

출처 데이터셋750 AstraZeneca ELN dataset
ORD IDord-c0ea6369f2d042108e16225bf99070cf
출처 메모750 AstraZeneca ELN dataset